LivingGLP1
Study S002143

Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1-based Therapy Discontinuation

Registration

Registration
NCT07729332
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
NONE
Status
NOT_YET_RECRUITING
Enrollment
60
Start
2026-11-01
Primary completion
2031-07-31
Lead sponsor
Massachusetts General Hospital
Conditions
Obesity
Interventions
DRUG:Phentermine Pill; DRUG:Orforglipron
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • Percent change in body weight [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.